The Scientist

» monoclonal antibodies

Most Recent

image: Cautious Optimism About ZMapp Trial

Cautious Optimism About ZMapp Trial

By | February 25, 2016

The Ebola drug increased survival in a small study, but the effect was not statistically significant.

0 Comments

image: Single Antibody Protects Macaques from Ebola

Single Antibody Protects Macaques from Ebola

By | February 25, 2016

The Ebola drug increased survival in a small study, but the effect was not statistically significant.

0 Comments

image: In Situ Antibodies

In Situ Antibodies

By | February 2, 2016

The Ebola drug increased survival in a small study, but the effect was not statistically significant.

2 Comments

image: Antibody Alternatives

Antibody Alternatives

By and | February 1, 2016

The Ebola drug increased survival in a small study, but the effect was not statistically significant.

2 Comments

image: Exercises for Your Abs

Exercises for Your Abs

By | February 1, 2016

The Ebola drug increased survival in a small study, but the effect was not statistically significant.

3 Comments

image: Building Better Reagents

Building Better Reagents

By and | February 1, 2016

The Ebola drug increased survival in a small study, but the effect was not statistically significant.

0 Comments

The Ebola drug increased survival in a small study, but the effect was not statistically significant.

1 Comment

image: Two-Faced Proteins May Tackle HIV Reservoirs

Two-Faced Proteins May Tackle HIV Reservoirs

By | October 21, 2015

The Ebola drug increased survival in a small study, but the effect was not statistically significant.

0 Comments

image: Novartis Buys Rights to GSK MS Drug for $1 Billion

Novartis Buys Rights to GSK MS Drug for $1 Billion

By | August 24, 2015

The Ebola drug increased survival in a small study, but the effect was not statistically significant.

0 Comments

image: Moving MERS Therapies Forward

Moving MERS Therapies Forward

By | July 28, 2015

The Ebola drug increased survival in a small study, but the effect was not statistically significant.

3 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech